Brannan Stephen K.
SEC insider (Form 3/4/5 filer). CIK 0001777631. Director at Serina Therapeutics, Inc. (SER). 4 reported Form 4/5 transactions since Sep 2024; latest on Jul 7, 2026. Located in HUNTSVILLE, AL.
Companies Brannan Stephen K. has filed insider reports for
- Serina Therapeutics, Inc. (SER): Director
Brannan Stephen K.
CIK: 0001777631
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Serina Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jul 7, 2026SER
Serina Therapeutics, Inc.
PurchaseDirect1K shares at avg. $2.03$2K - Jun 17, 2026SER
Serina Therapeutics, Inc.
AwardDirectStock Option (right to buy)
15.3K shares- - Nov 7, 2025SER
Serina Therapeutics, Inc.
AwardDirectStock Option (right to buy)
10K shares- - May 22, 2025SER
Serina Therapeutics, Inc.
AwardDirectStock Option (right to buy)
40K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 7, 2026 | SER Serina Therapeutics, Inc. | Purchase | 1,000 | $2.03 | $2,030 | Direct |
| Jun 17, 2026 | SER Serina Therapeutics, Inc. | Award Stock Option (right to buy) | 15,250 | - | - | Direct |
| Nov 7, 2025 | SER Serina Therapeutics, Inc. | Award Stock Option (right to buy) | 10,000 | - | - | Direct |
| May 22, 2025 | SER Serina Therapeutics, Inc. | Award Stock Option (right to buy) | 40,000 | - | - | Direct |
1-4 of 4 transactions